<DOC>
	<DOC>NCT00293787</DOC>
	<brief_summary>The purpose of the study is to evaluate the safety and effectiveness of an investigational therapy for treating patients with open-angle glaucoma or ocular hypertension.</brief_summary>
	<brief_title>A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>18 years or older. Diagnosis of openangle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension. Mean IOP in each eye less than 18 mmHg at the screening visit. Other protocoldefined inclusion criteria may apply. Pregnant. History of chronic or recurrent severe inflammatory eye disease. Ocular trauma within the past six months in either eye. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Open-angle</keyword>
	<keyword>glaucoma</keyword>
	<keyword>ocular</keyword>
	<keyword>hypertension</keyword>
</DOC>